People with Hepatitis D have up to three times the risk of developing fatal liver cancer
Of all the hepatitis viruses, D is the most poorly known. This small virus, which can only infect people already infected with Hepatitis B, has so far been little studied.
15 days ago - News Medical
People infected with hepatitis D are more prone to hepatocellular carcinoma
Of all the hepatitis viruses, D is the most poorly known.This small virus, which can only infect people already infected with Hepatitis B, has so far been little studied.
15 days ago - News Medical
Worse COVID-19 Outcomes With Liver Injury at Presentation
Gastrointestinal and hepatic manifestations of COVID-19 are common, but only liver injury at presentation is associated with an increased risk of death or ICU admission...
17 days ago - Medscape - 2 articles
Universal screening reveals ‘striking' HCV antibody prevalence in people born after 1965
Universal hepatitis C virus screening in EDs with the ability to opt out showed that nearly half of infections were identified in people born after 1965, according to findings...
18 days ago - Healio
Hepatitis A and E cases rise; Listeria and norovirus fall in Scotland
Health Protection Scotland has published annual surveillance reports for Listeria, hepatitis A and E, norovirus, Shigella and Yersinia. Data shows a decline in Listeria...
19 days ago - Food Safety
Clinical trial to test the efficacy of defibrotide medicine for reducing COVID-19 death rate
The Neurosciences Institute, mixed centre of the Spanish National Research Council and the Miguel Hernández University of Elche, have collaborated on the first clinical trial...
21 days ago - News Medical - 3 articles
Researchers Develop Pharmacotherapy To Treat Polycystic Hepatorena
Researchers developed new drugs which are effective in reducing the growth of hepatic and renal cysts in experimental models, which could be of huge clinical significance.
21 days ago - Medindia Health
Study identifies protein vital for liver restoration and regeneration after transplant
Researchers from the Faculty of Medicine of the University of Barcelona and the CELLEX Biomedical Research Centre from IDIBAPS have identified in a study with mice a protein...
27 days ago - News Medical
Supercomputer simulations present potential active substances against coronavirus
Several drugs approved for treating hepatitis C viral infection were identified as potential candidates against COVID-19, the disease caused by the SARS-CoV-2 coronavirus. This...
28 days ago - ScienceDaily
Inventor of hepatitis C cure wins prestigious award from University of Edinburgh
A medicinal chemist who found a cure for the viral disease hepatitis C has received a prestigious award from the University of Edinburgh.
30 days ago - News Medical
The headlines of Master Doctor
Rural Psychiatric Care in the Time of COVID-19
In writing this, I feel a bit strange to contribute my thoughts on a pandemic I've had mostly a peripheral experience with. In my brief month on the medicine ward, I did...
Experts admit it was possible Covid-19 was in the UK in DECEMBER
Andy Gill, 64, had returned from a band trip to China in late November and was struck down with a mystery respiratory illness in December. He died of pneumonia in early January.
Does the cure for covid-19 already exist? Andreas Kalcker interviewed about...
Every intelligent person is already aware that the pharma-controlled medical establishment and lamestream media rolled out a coordinated smear campaign against...
COVID-19 Testing Supplies Still Needed, Lawmakers Told
WASHINGTON - Democrats and Republicans alike agreed at a House hearing Tuesday on the importance of ramping up testing for COVID-19, but they couldn't agree on whether the...
Revenue Drying Up for Clinics Shuttered by COVID-19
When Todd J. Maltese, DO, shut down his neurology clinic in March, he estimated revenue generated through telemedicine appointments would be enough to last him 3 months. It...
Flu researchers say we should make a NEW antiviral to stop coronavirus
A new study from the University of Texas at Austin say researched need to create a new drug that stops the virus from multiplying rather then repurposing old drugs for...
Type 1 Diabetes Costs $2,500 a Year With Insurance
Out-of-pocket costs for Americans with type 1 diabetes average $2,500 a year, a new study says.
Protests Pose Particular Risks for COVID-19 Transmission
Nationwide protests about racial injustice in the U.S. not only ignited a political powder keg, but could also be sparking increases in COVID-19 transmission just as the...
TRK Inhibitor Continues to Show Multi-Cancer Effects
Patients with a variety of cancers - with a common thread of harboring tropomyosin receptor kinase fusion pathology - responded to treatment with larotrectinib , according to...
COVID-19 Cases Drop in Warm Weather, But Not Much
In search of an answer, researchers at Mount Auburn Hospital in Cambridge, Mass., studied the effects of temperature, precipitation and sunlight on the number of COVID-19 cases...